Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The why and how of adaptive immune responses in ischemic cardiovascular disease
Ziad Mallat, Christoph J. Binder
Nature Cardiovascular Research (2022) Vol. 1, Iss. 5, pp. 431-444
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Autoimmune diseases and atherosclerotic cardiovascular disease
Florentina Porsch, Christoph J. Binder
Nature Reviews Cardiology (2024) Vol. 21, Iss. 11, pp. 780-807
Closed Access | Times Cited: 29
Advancements in risk stratification and management strategies in primary cardiovascular prevention
Fotios Barkas, Yusuf Ziya Şener, Pelin Golforoush, et al.
Atherosclerosis (2024) Vol. 395, pp. 117579-117579
Closed Access | Times Cited: 16
Apolipoprotein B-containing lipoproteins in atherogenesis
Jan Borén, Chris J. Packard, Christoph J. Binder
Nature Reviews Cardiology (2025)
Closed Access | Times Cited: 2
Cardiovascular Brain Circuits
Sarajo K. Mohanta, Changjun Yin, Christian Weber, et al.
Circulation Research (2023) Vol. 132, Iss. 11, pp. 1546-1565
Open Access | Times Cited: 32
Atherosclerosis from Newborn to Adult—Epidemiology, Pathological Aspects, and Risk Factors
Alina-Costina Luca, Simona Georgiana David, Alexandru Gabriel David, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2056-2056
Open Access | Times Cited: 29
Inflammation and Atherosclerosis: Prospects for Clinical Trials
Hafid Aït-Oufella, Peter Libby
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 9, pp. 1899-1905
Closed Access | Times Cited: 15
Marginal zone B cells produce ‘natural’ atheroprotective IgM antibodies in a T cell–dependent manner
J. B. Harrison, Stephen A. Newland, Wei Jiang, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 3, pp. 318-328
Open Access | Times Cited: 12
Lifestyle factors as determinants of atherosclerotic cardiovascular health
Arno Schmidt‐Trucksäss, Alice H. Lichtenstein, Roland von Känel
Atherosclerosis (2024) Vol. 395, pp. 117577-117577
Open Access | Times Cited: 12
Macrophage mediators and mechanisms in cardiovascular disease
Patrik Schelemei, Elena Wagner, Felix S.R. Picard, et al.
The FASEB Journal (2024) Vol. 38, Iss. 2
Open Access | Times Cited: 10
Pleiotropic genetic architecture and novel loci for C-reactive protein levels
Fotios Koskeridis, Εvangelos Εvangelou, Saredo Said, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 38
Inflammaging, immunosenescence, and cardiovascular aging: insights into long COVID implications
Ludmila Müller, Svetlana Di Benedetto
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 8
Bioactive compounds of foods: Phytochemicals and peptides
Janifer Raj Xavier, Barde Sameer Sanjay, Dayashankar Gupta, et al.
Food and Humanity (2024) Vol. 3, pp. 100354-100354
Closed Access | Times Cited: 7
Costimulatory and Coinhibitory Immune Checkpoints in Atherosclerosis
Katrin Nitz, Joerg Herrmann, Amir Lerman, et al.
JACC Basic to Translational Science (2024) Vol. 9, Iss. 6, pp. 827-843
Open Access | Times Cited: 6
Antigen presentation plays positive roles in the regenerative response to cardiac injury in zebrafish
João Cardeira-da-Silva, Qianchen Wang, Pooja Sagvekar, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Two decades of vaccine development against atherosclerosis
Miguel A. Moreno‐Gonzalez, Oscar A. Ortega‐Rivera, Nicole F. Steinmetz
Nano Today (2023) Vol. 50, pp. 101822-101822
Open Access | Times Cited: 14
New Insights into Pathophysiology and New Risk Factors for ACS
Matteo Nardin, Monica Verdoia, Nicola Laera, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 8, pp. 2883-2883
Open Access | Times Cited: 12
Adaptive immunity and atherosclerosis: aging at its crossroads
Roy P. M. Snijckers, Amanda C. Foks
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Crosstalk between efferocytic myeloid cells and T-cells and its relevance to atherosclerosis
David Ngai, Santosh R. Sukka, Ira Tabas
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseases
Maya H Buch, Ziad Mallat, Marc R. Dweck, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 10, pp. 614-634
Closed Access | Times Cited: 4
Enhanced Adsorption Capacity and Specificity for Recognition of low-density lipoprotein (LDL) with Resorcinol-Formaldehyde Nanospheres and Aptamer Decorated Graphene Oxide Nanocomposites
Jian-Fang Cao, Peng Hu, Pengfei Du, et al.
Journal of Chromatography A (2025) Vol. 1743, pp. 465697-465697
Closed Access
Roadmap for alleviating the manifestations of ageing in the cardiovascular system
Luca Liberale, Simon Tual‐Chalot, Simon Sedej, et al.
Nature Reviews Cardiology (2025)
Closed Access
Trans 10, cis 12-conjugated linoleic acid alleviates vascular fibrosis in obese mice
Shuai Yu, Yu Rao, Jiaqi Lu, et al.
Prostaglandins Leukotrienes and Essential Fatty Acids (2025) Vol. 204, pp. 102669-102669
Closed Access
Role of monocytes/macrophages in renin-angiotensin system-induced hypertension and end organ damage
Tlili Barhoumi, Stephen Todryk
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 8
Control of the post-infarct immune microenvironment through biotherapeutic and biomaterial-based approaches
Shreya S. Soni, Arielle M. D’Elia, Christopher B. Rodell
Drug Delivery and Translational Research (2023) Vol. 13, Iss. 7, pp. 1983-2014
Open Access | Times Cited: 4
Mapping the functions of IgM antibodies in atherosclerotic cardiovascular disease
Justine Deroissart, Christoph J. Binder
Nature Reviews Cardiology (2023) Vol. 20, Iss. 7, pp. 433-434
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top